Cannabinoids For Digestive Health
Both CBD & CBG have mounting research in their efficacy in helping people control the various symptoms of GI disorders.
CB1 receptors are found throughout the gastrointestinal system and central nervous system and CB2 receptors are found in the immune system. While the digestive system is the obvious target for most conditions, inflammatory diseases have immune system contributing factors and our central nervous system communicates our physical pain.
Ingesting CBD and CBG for digestive health will stimulate both CB1 and CB2 receptors. That is because these two cannabinoids can stimulate both receptors.(1)
Collectively, these cannabinoids work with the endocannabinoid systems complex network of receptors to (2):
- Collectively these receptors
- Regulate food intake
- Eliminate nausea and vomiting
- Balance stomach secretions
- Offer stomach protection
- Regulate GI motility & movement
- Reduce stomach and intestinal sensation/pain
- Maintain proper fluid and electrolyte balance
- Control inflammation from certain GI illnesses
- Ensure the proper number of cells within the GI tract
Studies have concluded that CBD and CBG among other cannabinoids and terpenes can diminish gastrointestinal distress and aid in the treatment of a wide array of GI related diseases and disorders including but not limited to: Irritable Bowel Syndrome (IBS), Irritable Bowel Disease (IBD), Crohn’s Disease, Gas, Diarrhea, Diverticulosis, Diverticulitis, Acid Reflux including GERD and GER, Ulcers and Celiac Disease.
It has also been shown that CBD can positively impact receptors outside the ECS that affect many diseases such as Crohn’s Disease and that select terpenes can stimulate the vagus nerve which boosts the body’s general immune response.(2)
The Mutual Relationship Between Sleep Disorders and IBD(3)
In a 2018 study published “Sleep disorders in Inflammatory Bowel Disease: The Forgotten Discussion, the authors reiterated that sleep disturbances and inflammatory conditions is moderately understood.
Studies have shown that inflammatory bowel disease (IBD) patients:
Have poorer sleep quality.
Go longer without sleep (insomnia).
Increased use of sleeping pills and OTC drugs.
This study evaluated gastroenterology assessment records for the sleep patterns of IBD patients. Its findings showed how significantly worse a patient’s sleep is when their IBD is active vs. inactive. Of further interest, if patients continued to have abnormal sleep patterns, even when in remission, they had increased episodes of relapse when compared to IBD sufferers that did not have documented disturbed sleep issues.
Medical research continues to substantiate the seemingly revolving door of sleep disorders and chronic illness, as they are often not singular entities but often a symptom of the other.
The endocannabinoid system, a “master regulator,” acts as a link or communicator with all our regulatory systems, seemingly multi-dimensionally, in very complex chemical communications, all processes working to achieve and maintain homeostasis. Our digestive system is one of these systems.
For most individuals, being diagnosed with a GI disorder or disease will mean a lifetime of medications, harsh dietary restrictions and symptoms that can restrict one’s quality of daily life in and life outside of the home. Cannabinoids are supportive compounds in keeping our endocannabinoid system active in regulating our digestive system and immune system.
DIGESTIVE HEALTH PRODUCTS
One World Live Digestive Elixir
OWL Digestive Elixir is a full-spectrum CBD oil enhanced with terpenes. OWL Digestive Elixir is a standardized, lab-tested cannabidiol extract with 600 milligrams of CBD and powerful terpene actives. OWL Digestive Elixir was designed to improve gastric health: regulate food intake, calm nausea and reduce pain and inflammation.